LOTUSEYE — Lotus Eye Hospital and Institute Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual income statement for Lotus Eye Hospital and Institute, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	389	470	482	496	537
Cost of Revenue
Gross Profit	206	251	253	247	261
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	356	424	450	487	541
Operating Profit	33.6	46.1	32.4	8.66	-3.67
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	40.9	56.5	40.1	13.8	-0.536
Provision for Income Taxes
Net Income After Taxes	29.8	40.8	29.1	7.39	0.804
Net Income Before Extraordinary Items
Net Income	29.8	40.8	29.1	7.39	0.804
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	29.8	40.8	29.1	7.39	0.804
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.44	1.96	1.4	0.357	0.041
Dividends per Share